亚胺培南 美罗培南 药动学/药效学(PK/PD)的差异 实战 PK/PD 小结
1. Rodloff AC, Goldstein EJC, Torres A. Two decades of imipenem therapy. J Antimicrob Chemother 2006;58:916–29. doi: 10.1093/jac/dkl354. 2. Williams PD, Bennett DB, Comereski CR. Animal model for evaluating the convulsive liability of beta-lactam antibiotics. Antimicrob Agents Chemother 1988;32:758–60. doi: 10.1128/AAC.32.5.758. 3. Zhanel GG, Wiebe R, Dilay L, Thomson K, Rubinstein E, Hoban DJ, et al. Comparative review of the carbapenems. Drugs 2007;67:1027–52. doi: 10.2165/00003495-200767070-00006. 4. Grayson ML, editor. Kucers』 the use of antibiotics: a clinical review of antibacterial, antifungal, antiparasitic and antiviral drugs., Seventh edition. Boca Raton: CRC Press; 2017. 5. CHINET 中国细菌耐药监测网. http://www./Data/GermYear. 6. 王明贵. 耐药革兰阴性菌感染诊疗手册. 人民卫生出版社, 2015. 7. Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 2016;63:e61–111. doi: 10.1093/cid/ciw353. |
|